Holland & Barrett Femlieve

Holland & Barrett Femlieve is an over‑the‑counter oral herbal supplement containing a standardized Vitex agnus‑castus fruit dry extract (7‑13 : 1) prepared with 60 % ethanol. The product is marketed in the EU and is intended to support menstrual health and hormonal balance. It is supplied in a convenient oral dosage form. Each dose provides a consistent amount of the active phytochemicals, and the formulation complies with EU food supplement regulations.

Femlieve is positioned for women who experience hormonal fluctuations related to the menstrual cycle. Clinical and traditional use suggest it may be helpful for the following conditions:

- Premenstrual syndrome (PMS) characterised by mood swings, breast tenderness and bloating. - Irregular menstrual cycles, including delayed or missed periods. - Luteal phase support to promote a more stable post‑ovulatory phase. - Mild menstrual discomfort such as cramps or lower‑back pain. - Hormonal imbalances that may affect skin or hair health.

Adverse reactions to Femlieve are generally mild, but users should be aware of both common and less frequent serious events.

Common: - Mild gastrointestinal upset such as nausea or stomach discomfort. - Headache or transient dizziness. - Slight fatigue or drowsiness.

Serious: - Allergic skin reactions including rash, itching or swelling. - Signs of hormonal disturbance such as unexpected breast enlargement or galactorrhoea. - Severe abdominal pain that persists. - Any indication of liver dysfunction (e.g., jaundice).

Before starting Femlieve, consider the following precautionary points to minimise risk.

- Not recommended for pregnant or breastfeeding women without professional guidance. - Individuals with known hypersensitivity to Vitex or ethanol should avoid use. - Those taking hormonal therapies (e.g., contraceptives, hormone replacement) should consult a healthcare professional. - Patients with endocrine disorders such as prolactinoma or thyroid disease need medical advice prior to use. - Persons scheduled for surgery should discontinue use several weeks beforehand due to potential hormonal effects. - Keep out of reach of children.

Femlieve may interact with certain medicines or supplements; awareness of these interactions can help prevent adverse outcomes.

Avoid: - Dopamine antagonists (e.g., antipsychotics such as haloperidol) that could counteract Vitex’s dopaminergic activity. - Hormonal contraceptives or hormone replacement therapy, where combined use may alter hormone levels. - Antidepressants that affect serotonin or dopamine pathways (e.g., SSRIs, MAO inhibitors).

Use with caution: - Anticoagulant or antiplatelet agents, as Vitex may have mild effects on platelet aggregation. - Herbal products with similar hormonal activity, such as chasteberry or black cohosh. - Medications metabolised by CYP450 enzymes, pending further evidence.